Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

16.330
-0.180-1.09%
Volume:6.40M
Turnover:104.36M
Market Cap:43.37B
PE:10.99
High:16.500
Open:16.440
Low:16.100
Close:16.510
52wk High:28.232
52wk Low:14.505
Shares:2.66B
HK Float Shares:538.00M
Volume Ratio:0.96
T/O Rate:1.19%
Dividend:0.46
Dividend Rate:2.79%
EPS(LYR):1.486
ROE:6.95%
ROA:1.40%
PB:0.76
PE(LYR):10.99
PS:0.87

Loading ...

Fosun Pharma Receives NMPA Nod for Luvometinib’s Adult NF1 Plexiform Neurofibroma Indication

Bulletin Express
·
Sep 03

Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets of Unit Approved by Nmpa China

THOMSON REUTERS
·
Sep 03

Shanghai Fosun Pharmaceutical Secures Regulatory Nod for Expanded Use of Lung Cancer Drug

Stock News
·
Sep 03

Regent Pacific Gets $4.5 Million Milestone Payment from Fosun Pharma Unit

MT Newswires Live
·
Sep 01

Fosun Pharma Repurchases 264,000 H Shares, Reducing Free Float by 0.05%

Bulletin Express
·
Sep 01

Fosun Pharma Spends HK$4.28 Million on Share Buyback on September 1

Stock News
·
Sep 01

Fosun Pharma Repurchases 70,500 H Shares for HKD 1.13 Million, Boosting Treasury Stock to 11.26 Million

Bulletin Express
·
Aug 31

Fosun Pharma Allocates 725,100 A-Share Options to Employees

Stock News
·
Aug 28

Fosun Pharma Grants 0.73 Million A-Share Options at RMB 27.93 Each Under 2025 Scheme

Bulletin Express
·
Aug 28

Shanghai Fosun Pharmaceutical's GR1803 Injection Gets Conditional Approval in China

MT Newswires Live
·
Aug 28

Fosun Pharma Secures Conditional NMPA Approval for GR1803 Injection

Stock News
·
Aug 27

Shanghai Fosun Pharma - Recently, Marketing Registration Application for Gr1803 Injection Has Been Approved with Conditions by Nmpa China

THOMSON REUTERS
·
Aug 27

Fosun Pharma Completes HK$3.587 Million Share Buyback on August 27

Stock News
·
Aug 27

Sinopharm Group Stock Rallies 1.1% in Hong Kong

Dow Jones
·
Aug 26

Fosun Pharma's H1 Report: Innovative Drug Revenue Surges 13.8% as Global Expansion Spans Three Continents

Deep News
·
Aug 26

Fosun Pharma Posts Flat Profit Growth in H1, Revenue Up 4.8%

MT Newswires Live
·
Aug 26

Press Release: Fosun Pharma Announces 2026 Interim Results

Dow Jones
·
Aug 25

Sinopharm Group Stock Falls 1.9% in Hong Kong

Dow Jones
·
Aug 24

Earning Preview: FOSUN PHARMA this quarter’s revenue is expected to increase by 8.56%, and institutional views are broadly bullish

Earnings Agent
·
Aug 18

Fosun Pharma Subsidiary Enters Collaboration Framework and License Agreement

Stock News
·
Aug 17